Titre : Maladie des légionnaires

Maladie des légionnaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladie des légionnaires : Questions médicales les plus fréquentes", "headline": "Maladie des légionnaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladie des légionnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-22", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladie des légionnaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Légionellose", "url": "https://questionsmedicales.fr/mesh/D007876", "about": { "@type": "MedicalCondition", "name": "Légionellose", "code": { "@type": "MedicalCode", "code": "D007876", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.730.382" } } }, "about": { "@type": "MedicalCondition", "name": "Maladie des légionnaires", "alternateName": "Legionnaires' Disease", "code": { "@type": "MedicalCode", "code": "D007877", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sophie Jarraud", "url": "https://questionsmedicales.fr/author/Sophie%20Jarraud", "affiliation": { "@type": "Organization", "name": "Institut des Agents Infectieux, Centre National de Référence des Légionelles, Hospices Civils de Lyon, Lyon, France. sophie.jarraud@univ-lyon1.fr." } }, { "@type": "Person", "name": "Chris Edens", "url": "https://questionsmedicales.fr/author/Chris%20Edens", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Christophe Ginevra", "url": "https://questionsmedicales.fr/author/Christophe%20Ginevra", "affiliation": { "@type": "Organization", "name": "The National Reference Center of Legionella, 69317 Lyon, France." } }, { "@type": "Person", "name": "Lara Payne Hallström", "url": "https://questionsmedicales.fr/author/Lara%20Payne%20Hallstr%C3%B6m", "affiliation": { "@type": "Organization", "name": "European Centre for Disease Prevention and Control (ECDC), Solna, Sweden." } }, { "@type": "Person", "name": "Kelsie Cassell", "url": "https://questionsmedicales.fr/author/Kelsie%20Cassell", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, Connecticut." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Kenward-Roger-type corrections for inference methods of network meta-analysis and meta-regression.", "datePublished": "2023-07-03", "url": "https://questionsmedicales.fr/article/37399845", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jrsm.1652" } }, { "@type": "ScholarlyArticle", "name": "Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.", "datePublished": "2024-09-18", "url": "https://questionsmedicales.fr/article/39293856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1183/16000617.0046-2024" } }, { "@type": "ScholarlyArticle", "name": "Topical anti-inflammatory treatments for eczema: network meta-analysis.", "datePublished": "2024-08-06", "url": "https://questionsmedicales.fr/article/39105474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD015064.pub2" } }, { "@type": "ScholarlyArticle", "name": "Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.", "datePublished": "2023-08-31", "url": "https://questionsmedicales.fr/article/37650547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD013730.pub2" } }, { "@type": "ScholarlyArticle", "name": "Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36691161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-063884" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Infections de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012141" }, { "@type": "ListItem", "position": 4, "name": "Légionellose", "item": "https://questionsmedicales.fr/mesh/D007876" }, { "@type": "ListItem", "position": 5, "name": "Maladie des légionnaires", "item": "https://questionsmedicales.fr/mesh/D007877" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladie des légionnaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladie des légionnaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladie des légionnaires", "description": "Comment diagnostique-t-on la maladie des légionnaires ?\nQuels tests sont utilisés pour confirmer l'infection ?\nLes radiographies sont-elles utiles pour le diagnostic ?\nQuels symptômes orientent vers un diagnostic de légionellose ?\nLa biopsie pulmonaire est-elle nécessaire pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladie des légionnaires", "description": "Quels sont les symptômes courants de la maladie des légionnaires ?\nLa diarrhée est-elle un symptôme possible ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques chez les personnes âgées ?\nLa confusion mentale est-elle un symptôme associé ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladie des légionnaires", "description": "Comment prévenir la maladie des légionnaires ?\nLes systèmes de climatisation doivent-ils être surveillés ?\nLes personnes à risque doivent-elles prendre des précautions ?\nLes douches peuvent-elles être une source de contamination ?\nDes vaccins existent-ils pour prévenir cette maladie ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladie des légionnaires", "description": "Quel est le traitement principal de la maladie des légionnaires ?\nLes corticostéroïdes sont-ils recommandés ?\nQuelle est la durée du traitement antibiotique ?\nDes soins de soutien sont-ils nécessaires ?\nLes patients doivent-ils être hospitalisés ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladie des légionnaires", "description": "Quelles sont les complications possibles de la légionellose ?\nLa maladie peut-elle entraîner des séquelles ?\nLes personnes âgées sont-elles plus à risque de complications ?\nComment les complications sont-elles gérées ?\nLe décès est-il possible en cas de légionellose ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladie des légionnaires", "description": "Quels sont les principaux facteurs de risque ?\nLes fumeurs sont-ils plus susceptibles de contracter la maladie ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes voyages peuvent-ils augmenter le risque d'infection ?\nLes antécédents de pneumonie augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D007877?mesh_terms=Network+Meta-Analysis&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la maladie des légionnaires ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests de culture des expectorations ou des analyses sanguines." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'infection ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les tests d'antigènes urinaires sont couramment utilisés." } }, { "@type": "Question", "name": "Les radiographies sont-elles utiles pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les radiographies thoraciques montrent souvent des infiltrats pulmonaires." } }, { "@type": "Question", "name": "Quels symptômes orientent vers un diagnostic de légionellose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, toux, dyspnée et douleurs thoraciques sont des indicateurs clés." } }, { "@type": "Question", "name": "La biopsie pulmonaire est-elle nécessaire pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, elle est utilisée si les autres tests ne sont pas concluants." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la maladie des légionnaires ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, toux, essoufflement, douleurs musculaires et maux de tête sont fréquents." } }, { "@type": "Question", "name": "La diarrhée est-elle un symptôme possible ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la diarrhée peut survenir chez certains patients atteints de légionellose." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître 2 à 10 jours après l'exposition à la bactérie." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les personnes âgées ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent présenter des symptômes plus graves et des complications." } }, { "@type": "Question", "name": "La confusion mentale est-elle un symptôme associé ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la confusion ou des troubles neurologiques peuvent se manifester dans les cas graves." } }, { "@type": "Question", "name": "Comment prévenir la maladie des légionnaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir les systèmes d'eau propres et contrôler la température de l'eau est essentiel." } }, { "@type": "Question", "name": "Les systèmes de climatisation doivent-ils être surveillés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les systèmes de climatisation doivent être régulièrement entretenus pour éviter la contamination." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles prendre des précautions ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées et immunodéprimées doivent éviter les environnements à risque." } }, { "@type": "Question", "name": "Les douches peuvent-elles être une source de contamination ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les douches peuvent libérer des aérosols contenant la bactérie Legionella." } }, { "@type": "Question", "name": "Des vaccins existent-ils pour prévenir cette maladie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin efficace contre la maladie des légionnaires." } }, { "@type": "Question", "name": "Quel est le traitement principal de la maladie des légionnaires ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques, comme la lévofloxacine ou l'azithromycine, sont utilisés." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils recommandés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne sont généralement pas recommandés, sauf en cas de complications sévères." } }, { "@type": "Question", "name": "Quelle est la durée du traitement antibiotique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dure généralement 10 à 14 jours, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Des soins de soutien sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'oxygénothérapie et l'hydratation peuvent être nécessaires pour les patients graves." } }, { "@type": "Question", "name": "Les patients doivent-ils être hospitalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité des symptômes; les cas sévères nécessitent souvent une hospitalisation." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la légionellose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance respiratoire, le choc septique et la défaillance multiviscérale." } }, { "@type": "Question", "name": "La maladie peut-elle entraîner des séquelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent avoir des séquelles pulmonaires à long terme." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves et de mortalité." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications nécessitent souvent des soins intensifs et un traitement symptomatique." } }, { "@type": "Question", "name": "Le décès est-il possible en cas de légionellose ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la légionellose peut être mortelle, surtout chez les personnes à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, le tabagisme, et les maladies chroniques." } }, { "@type": "Question", "name": "Les fumeurs sont-ils plus susceptibles de contracter la maladie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de développer une légionellose." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées ont un risque accru d'infection sévère." } }, { "@type": "Question", "name": "Les voyages peuvent-ils augmenter le risque d'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des zones avec des systèmes d'eau contaminés augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents de pneumonie augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de pneumonie peut prédisposer à la légionellose." } } ] } ] }

Sources (10000 au total)

Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis.

With recent advancements in bronchoscopic procedures, data on the best modality to sample peripheral pulmonary lesions (PPLs) is lacking, especially comparing bronchoscopy with computed tomography-gui... We performed a meta-analysis, pairwise meta-analysis and network meta-analysis on studies reporting diagnostic yield and complications with the use of CT-TBNA, radial endobronchial ultrasound (rEBUS),... We included 363 studies. The overall pooled diagnostic yield was 78.1%, the highest with CT-TBNA (88.9%), followed by RAB (84.8%) and the least with rEBUS (72%). In the pairwise meta-analysis, only rE... Although CT-TBNA is the most effective approach to sample PPLs, RAB has a comparable diagnostic yield with a lesser complication rate. Further prospective studies are needed comparing CT-TBNA and RAB....

Topical anti-inflammatory treatments for eczema: network meta-analysis.

Eczema (atopic dermatitis) is the most burdensome skin condition worldwide and cannot currently be prevented or cured. Topical anti-inflammatory treatments are used to control eczema symptoms, but the... To compare and rank the efficacy and safety of topical anti-inflammatory treatments for people with eczema using a network meta-analysis.... We searched the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase and trial registries on 29 June 2023, and checked the reference lists of included studies.... We included within-participant or between-participant randomised controlled trials (RCTs) in people of any age with eczema of any severity, but excluded trials in clinically infected eczema, seborrhoe... We used standard Cochrane methods. Primary outcomes were patient-reported eczema symptoms, clinician-reported eczema signs and investigator global assessment. Secondary outcomes were health-related qu... We included 291 studies involving 45,846 participants with the full spectrum of eczema severity, mainly conducted in high-income countries in secondary care settings. Most studies included adults, wit... Potent TCS, JAK inhibitors and tacrolimus 0.1% were consistently ranked as amongst the most effective topical anti-inflammatory treatments for eczema and PDE-4 inhibitors as amongst the least effectiv...

Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.

Despite considerable improvement in outcomes for preterm infants, rates of bronchopulmonary dysplasia (BPD) remain high, affecting an estimated 33% of very low birthweight infants, with corresponding ... To determine whether differences in efficacy and safety exist between high-dose dexamethasone, moderate-dose dexamethasone, low-dose dexamethasone, hydrocortisone, and placebo in the prevention of BPD... We searched the Cochrane Library for all systematic reviews of systemic corticosteroids for the prevention of BPD and searched for completed and ongoing studies in the following databases in January 2... We included randomized controlled trials (RCTs) in preterm infants (< 37 weeks' gestation) at risk for BPD that evaluated systemic corticosteroids (high-dose [≥ 4 mg/kg cumulative dose] dexamethasone,... Our main information sources were the systematic reviews, with reference to the original manuscript only for data not included in these reviews. Teams of two paired review authors independently perfor... We included 59 studies, involving 6441 infants, in our analyses. Only six of the included studies provided direct comparisons between any of the treatment (dexamethasone or hydrocortisone) groups, for... Low-dose dexamethasone increased the risk for cerebral palsy (RR 1.92, 95% CI 1.12 to 3.28; moderate-certainty evidence) compared with control. Hydrocortisone may decrease the risk of major neurosenso... No effect was observed for the outcomes of major neurosensory disability or cerebral palsy. The evidence for the primary outcomes was of overall low certainty, with notable deductions for imprecision ... While early treatment with moderate-dose dexamethasone or late treatment with high-dose dexamethasone may lead to the best effects for survival without BPD, the certainty of the evidence is low. There...

Percutaneous coronary intervention in calcified stenoses: a protocol for a systematic review with meta-analysis, trial sequential analysis and network meta-analysis.

Severely calcified coronary stenoses are difficult to treat with percutaneous coronary interventions. The presence of severe calcifications complicates lesion preparation, advancement of stents and ac... We will conduct a systematic review of randomised trials enrolling patients with calcified coronary artery disease undergoing percutaneous coronary intervention. We will investigate any percutaneous t... No ethics approval is required for this study. The results will be published in a peer-reviewed journal in this field.... CRD42021226034....

Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.

Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects mainly young adults (two to three times more frequently in women than in men) and causes significant disability ... To compare adverse effects of immunotherapies for people with MS or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects through networ... We searched CENTRAL, PubMed, Embase, two other databases and trials registers up to March 2022, together with reference checking and citation searching to identify additional studies.... We included participants 18 years of age or older with a diagnosis of MS or CIS, according to any accepted diagnostic criteria, who were included in randomized controlled trials (RCTs) that examined o... We used standard Cochrane methods for data extraction and pairwise meta-analyses. For NMAs, we used the netmeta suite of commands in R to fit random-effects NMAs assuming a common between-study varian... This NMA included 123 trials with 57,682 participants... We found mostly low and very low-certainty evidence that drugs used to treat MS may not increase SAEs, but may increase withdrawals compared with placebo. The results suggest that there is no importan...

Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis.

A comprehensive network meta-analysis comparing the effects of individual sodium-glucose cotransporter 2 (SGLT2) inhibitors on patients with and without comorbidities including diabetes mellitus (DM),... We searched PubMed, Embase, Cochrane, and ClinicalTrials.gov for randomized controlled trials up to March 28, 2023. Network meta-analysis using a random-effects model was conducted to calculate risk r... A total of fourteen trials with 75,334 patients were analyzed. Among these, 40,956 had taken SGLT2 inhibitors and 34,378 had not. One of the main results with particular findings was empagliflozin use... Our network meta-analysis revealed that empagliflozin users with diabetes experienced a lower risk of dying from any cause than those using dapagliflozin. Additionally, canagliflozin users demonstrate... PROSPERO [CRD42022361906]....

A network meta-analysis of surgical treatments of complete rectal prolapse.

Surgical treatment of complete rectal prolapse can be undertaken via an abdominal or a perineal approach. The present network meta-analysis aimed to compare the outcomes of different abdominal and per... A PRISMA-compliant systematic review of PubMed, Scopus, and Web of Science was conducted. Randomized clinical trials comparing two or more procedures for the treatment of complete rectal prolapse were... Nine randomized controlled trials with 728 patients were included. The follow-up ranged between 12 and 47 months. Posterior mesh rectopexy had significantly lower odds of recurrence than did the Altem... Posterior mesh rectopexy ranked best with the lowest recurrence while perineal procedures ranked worst with the highest recurrence rates....

Efficacy and safety of COVID-19 vaccines: A network meta-analysis.

Several vaccines showed a good safety profile and significant efficacy against COVID-19. Moreover, in the absence of direct head to head comparison between COVID-19 vaccines, a network meta-analysis t... Databases PubMed, CENTRAL, medRxiv, and clinicaltrials.gov were searched. Studies were included if they were placebo-controlled clinical trials and reported the safety profile and/or effectiveness of ... Forty-nine clinical trials that included 421,173 participants and assessed 28 vaccines were included in this network meta-analysis. The network meta-analysis showed that Pfizer is the most effective i... We found that almost all of the vaccines included in this study crossed the threshold of 50% efficacy. However, some of them did not reach the previously mentioned threshold against the B.1.351 varian...